ABSTRAa. Follow-up from birth to age 12 months was obtained in 21 infants born with intrauterine growth retardation. Serum insulin-like growth factor 1 was measured by radioimmunoassay. The bioassayable growth-promoting activity of the serum was measured as the "thymidine activity" on lectin-activated lymphocytes at 5 days and 1, 3, 6, 9, and 12 months, and was compared with control values. Depending on their length at age 12 months, the intrauterine growth retardation infants were divided into three groups: at or above the average (n = 8, group A), between the mean and -2 SD (n = 7, group B), or less than -2 SD (n = 6, group C). No differences in nutritional indexes or in head circumference were found between the three groups. Insulin-like growth factor 1 was significantly lower at age 5 days in intrauterine growth retardation than in control infants. It increased slowly in groups A and B to reach the control values at age 9 and 12 months. In group C it remained significantly subnormal at 1 yr of age. Thymidine activity was also significantly lower at age 5 days in intrauterine growth retardation compared with control infants. It increased sharply at age 1-3 months in groups A and B but remained significantly lower in group C up to 1 yr of age. Although individual values of insulinlike growth factor 1 and thymidine activity were closely correlated, the increase of length during the first postnatal year correlated significantly with the thymidine activity levels at 1 and 3 months but not with the insulin-like growth factor 1 levels at 1, 3, and 6 months. These data may be of some physiological significance for understanding the postnatal catch-up growth occurring after intrauterine growth retardation. (Pediatr Res 24: 380-383, 1988) Abbreviations IGF 1, insulin-like growth factor 1 TA, thymidine activity of serum IUGR, intra-uterine growth retardation SFD, small-for-dates newborns SGA, small for gestational age newborns AGA, appropriate for gestational age newborns that occurs in most but not all IUGR infants, usually in early postnatal life. The predictive value of various prenatal and neonatal parameters has been extensively discussed. However, although several studies have shown that somatomedin C/IGF l levels are lower in SFD than in normal-for-dates newborns (10-13), no longitudinal data on serum IGF 1 values in IUGR infants have been reported. The aim of this study was to follow the evolution of serum IGF 1 measured by radioimmunoassay and of the serum growth-promoting activity measured using a previously published bioassay (1 4) over a I -yr period in a group of IUGR infants compared to normal age-matched controls.
C it remained significantly subnormal at 1 yr of age. Thymidine activity was also significantly lower at age 5 days in intrauterine growth retardation compared with control infants. It increased sharply at age 1-3 months in groups A and B but remained significantly lower in group C up to 1 yr of age. Although individual values of insulinlike growth factor 1 and thymidine activity were closely correlated, the increase of length during the first postnatal year correlated significantly with the thymidine activity levels at 1 and 3 months but not with the insulin-like growth factor 1 levels at 1, 3, and 6 months. These data may be of some physiological significance for understanding the postnatal catch-up growth occurring after intrauterine growth retardation. (Pediatr Res 24: 380-383, 1988) Abbreviations IGF 1, insulin-like growth factor 1 TA, thymidine activity of serum IUGR, intra-uterine growth retardation SFD, small-for-dates newborns SGA, small for gestational age newborns AGA, appropriate for gestational age newborns that occurs in most but not all IUGR infants, usually in early postnatal life. The predictive value of various prenatal and neonatal parameters has been extensively discussed. However, although several studies have shown that somatomedin C/IGF l levels are lower in SFD than in normal-for-dates newborns (10) (11) (12) (13) , no longitudinal data on serum IGF 1 values in IUGR infants have been reported. The aim of this study was to follow the evolution of serum IGF 1 measured by radioimmunoassay and of the serum growth-promoting activity measured using a previously published bioassay (1 4) over a I -yr period in a group of IUGR infants compared to normal age-matched controls.
PATIENTS AND METHODS
A total of 21 infants (I 1 males and 10 females) with birth weight less than -2 SD according to Usher and McLean (15) was followed, up to the age of 12 months, with measurements of IGF 1 and TA at ages 5 days and 1, 3,6,9, and 12 months. The gestational age, birth weight, and birth length of the 21 IUGR infants are shown in Figure 1 . The gestational age was between 37 and 41 wk in 17 children, and 35-36 wk in four children.
The average birth weight was 2090 + SD 33 1 g, less than -2 SD for term in all. The average birth length was 45.09 * SD 2.58 cm, less than -2 SD for gestational age in 17 of the 2 1 children.
The mean head circumference was 3 1.74 + SD 1.34 cm, with a range of 28.5-33.7 cm. The mean ratio of the weight (kg) to the square value of the length (m), i.e. the nutrition index of Quetelet (16) Among the 21 newborns, none was the product of a multiple gestation. Six of the 2 1 mothers had developed hypertension in the last months of pregnancy; it was mild in four cases and more severe in two cases. There was no other history or evidence of major pathology. Two of the 2 1 mothers were smokers. One was later suspected of drinking alcohol in excess, but this remained uncertain. Delivew was vaginal for 15 of the infants and by cesarean section fo; six infants. The mean weight of the The early growth of born with IUGR, Or who were was 394 + SD 19 g in the normal range for length of gestation SFD, has been carefully studied by several authors (1) (2) (3) (4) (5) (6) (7) (8) (9) . The in all cases. T~~ of the placentas showed infarct& areas. The main emphasis of these rep0rts has been on the catch-u~ growth Apgar score was 9-10 in 13 newborns at 1 min and 9-10 in all Clinical examination and 2-ml blood sampling were performed at 5 days and then at 1, 3,6,9, and 12 months with the informed consent of the mother and after authorization from the ethical committee of the hospital. After 1 h at room temperature, serum was obtained by centrifugation and kept at -20" C until laboratory assays.
Serum IGF 1 was measured by radioimmunoassay after extraction on a Sep-Pak column using kits from Immuno Nuclear Corporation (Stillwater, MN). The sensitivity of the assay was 0.05 U/ml. Intraassay and interassay variations were less than 5%.
The ability of serum to stimulate thymidine uptake into lectinactivated human lymphocytes incubated in vitro was measured according to the technique previously described from this laboratory (14) ; this result is referred to as TA.
Serum IGF 1 and TA values obtained during the longitudinal study of the 2 1 IUGR infants were compared with control values obtained transversely from 62 normal healthy age-matched infants subjected to blood sampling for routine examinations.
RESULTS
Clinical data. The mean length of the 2 1 infants at 1 yr of age was 71.50 f SD 3.59 cm and their mean weight was 8.42 f SD 1.02 kg. According to the usual French growth charts (19) , eight infants (group A) had an average or above average length and weight at 12 months. The mean + SD length and weight for this group were 75 f 0.5 cm and 9.2 + 0.20 kg. In seven other infants (group B), length and weight at 12 months were within the normal 95% confidence limits according to the charts; their mean k SD length was 72 f 0.24 and weight 8.5 f 0.30 kg. The six other infants (group C) were less than -2 SD at 1 yr of age, with mean + SD length 67 + 1.1 cm and weight 7.3 + 0.37 kg. The two nutrition indexes of Quetelet (16) Fig. 2 . In the controls IGF 1 increased from 0.32 f 0.03 U/ml at 3 days to 0.50 + 0.06 at 1 month and 0.57 + 0.05 U/ml at 12 months. In the three groups of IUGR infants, mean IGF 1 values at 5 days were significantly (p < 0.00 1) lower than in control infants: 0.17 f 0.02 in group A and 0.16 f 0.02 in group B and C. The mean values increased slowly in groups A and B to reach the control values at age 9 and 12 months, respectively, whereas in group C it remained subnormal (0.3 1 f 0.03 U/ml) at age 12 months (p < 0.02 comparing group C with groups A and B or controls). No correlation was found between the IGF 1 values at ages 1, 3, and 6 months and the increase of length during the first postnatal year.
For TA measurements, the mean and SEM results are shown in Fig. 3 . In controls the mean TA value decreased from 1.33 f 0.07 U/ml at 5 days to 1.01 + 0.05 at 12 months. In the three (24), it is likely that they are less important than tissue levels of growth factors (25) . Insulin and related peptides (26) and probably other factors (27) also may contribute to the regulation of fetal growth. In a previous study from this laboratory we showed that fetal IGF 1 significantly increases between 21-24 and 25-28 wk from 0.05 f 0.06 to 0.24 f 0.03 U/ml, whereas TA significantly decreases from 1.4 1 f 0.15 to 0.95 f 0.05 U/ml (28) . In another study comparing sera from normal -and hypotrophic fetuses at midpregnancy, i.e. 19 to 24 wk, we showed a significantly lower bioassayable TA in hypotrophic (0.84 + SEM 0.04 U/ml) than in normal fetuses (1.28 f 0.09 U/ml) (29%), the TA levels decreasing from 19-22 to 23-24 wk shown lower somatomedin bioassavable activitv in SGA infants
There have been several longitudinal studies of the growth of infants born with IUGR of various causes. They demonstrate that catch-up growth occurs mainly during the first 6 to 9 postnatal months (5, 9) . SFD premature newborns have a better catch-up than SFD term newborns (I), and catch-up is better in those IUGR infants whose ultrasonographically measured cranial diameter had increased normally up to the 34th wk of pregnancy (4, 5) . A recent study comparing the height and weight at 5 yr with the length and weight at birth in 74 IUGR children and 148 controls showed that the height at 5 yr was significantly correlated with birth length in the IUGR children, but not in the controls (20) , although there was a significant correlation between the height at 5 yr and the parental height in the controls but not in the IUGR infants. On the contrary, in the present series, the height at 1 yr was correlated with midparental height. In the 21 IUGR newborns of the present study, the degree of catch-up in length did not relate to either the nutritional status at age 1 yr evaluated by the weightjsquare of length index and the arm/ head circumferences index, or to the head circumference itself.
Human fetal IGF levels have been studied by several groups. Sara et al. (21, 22) first identified a fetal somatomedin with characteristics different from those of adult IGF and more recently showed, using a fetal brain membrane radioreceptor assay, that circulating IGF levels of human fetuses between 16 and 28 wk of gestation include two components: IGF 2, and a "trun-0.1 1 versus 1.50 f 0.07).
Another study of TA (30) showed lower values in SGA (0.9 1 + SD 0.1 1) than in AGA neonates (1.23 f SD 0.60) in capillary blood obtained during the first 6 h after delivery. During the next 3 wk there was a significant increase of TA in the SGA compared with the AGA controls for whom TA remained unchanged. There was a strong positive correlation between TA and birth weight in the term SGA and preterm newborns, but not in the term newborns with normal weight. The postnatal data reported here suggest that both IGF 1 and TA are important for catch-up growth in IUGR infants. Both activities are significantly lower in IUGR than in controls at age 5 days, then rise in those IUGR infants who have more or less complete catch-up growth during their first year of life. There is little if any rise in infants whose length remains less than -2 SD at ages 6 and 12 months. It may be pointed out that the postnatal rise of TA is earlier and sharper than that of IGF 1, and that there is a significant positive correlation between the catch-up of growth and the TA values at 1 and 3 months. This correlation may be considered in the study of the postnatal catch-up growth occumng after IUGR. In the children of this study, the fact that IGF 1 levels at 1 and 3 months did not correlate with the increase in length may be of physiologic significance although the lower IGF 1 levels in the infants of group C might in some way reflect their poor postnatal growth. Further studies of the regulatory mechanisms controlling postnatal catch-up growth in SGA infants will be necessary for determining guidelines in the obstetrical and pediatric management of fetal growth retardation.
